BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9508209)

  • 1. Molecular abnormalities in lung cancer.
    Salgia R; Skarin AT
    J Clin Oncol; 1998 Mar; 16(3):1207-17. PubMed ID: 9508209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
    Bergh JC
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular genetics of human lung cancer.
    Slebos RJ; Rodenhuis S
    Eur Respir J; 1989 May; 2(5):461-9. PubMed ID: 2547647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.
    Guo L; Chen P; Zhou Y; Sun Y
    Exp Mol Pathol; 2010 Jun; 88(3):401-6. PubMed ID: 20206622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
    Sunaga N; Miyajima K; Suzuki M; Sato M; White MA; Ramirez RD; Shay JW; Gazdar AF; Minna JD
    Cancer Res; 2004 Jun; 64(12):4277-85. PubMed ID: 15205342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
    Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular and cellular basis of human lung cancer.
    Gazdar AF
    Anticancer Res; 1994; 14(1B):261-7. PubMed ID: 8166465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular biology of small cell lung cancer.
    Sattler M; Salgia R
    Semin Oncol; 2003 Feb; 30(1):57-71. PubMed ID: 12635090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
    Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
    Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advance on molecular and cellular biology of small cell lung cancer].
    Ji FY; Qian GS; Huang GJ
    Ai Zheng; 2005 Jul; 24(7):903-8. PubMed ID: 16004825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress in the biology of small cell bronchial carcinoma].
    Thomas F; Arriagada R; Le Chevalier T; Poupon MF
    Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
    Tang X; Liu D; Shishodia S; Ozburn N; Behrens C; Lee JJ; Hong WK; Aggarwal BB; Wistuba II
    Cancer; 2006 Dec; 107(11):2637-46. PubMed ID: 17078054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of placental growth factor gene in lung cancer.
    Woo IS; Park MJ; Byun JH; Hong YS; Lee KS; Park YS; Lee JA; Park YI; Ahn HK
    Tumour Biol; 2004; 25(1-2):1-6. PubMed ID: 15192305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle alterations and lung cancer.
    Vincenzi B; Schiavon G; Silletta M; Santini D; Perrone G; Di Marino M; Angeletti S; Baldi A; Tonini G
    Histol Histopathol; 2006 Apr; 21(4):423-35. PubMed ID: 16437388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells.
    Ravi RK; Thiagalingam A; Weber E; McMahon M; Nelkin BD; Mabry M
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):543-9. PubMed ID: 10100985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
    Schneider PM; Hung MC; Chiocca SM; Manning J; Zhao XY; Fang K; Roth JA
    Cancer Res; 1989 Sep; 49(18):4968-71. PubMed ID: 2569928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.